carbene has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Ji, LN; Li, Y; Mao, ZW; Wang, KN | 1 |
| Fiebig, HH; Fodor, E; Franz, MH; Freytag, M; Jones, PG; Kelter, G; Maftei, CV; Neda, I; Tamm, M | 1 |
| Cao, B; Che, CM; Fung, SK; Fung, YM; Hu, D; Lee, PY; Lok, CN; Zou, T | 1 |
3 other study(ies) available for carbene and Experimental Neoplasms
| Article | Year |
|---|---|
Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
Topics: A549 Cells; Animals; Antineoplastic Agents; Coordination Complexes; Humans; Iridium; Methane; Mice; Mice, Nude; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Xenograft Model Antitumor Assays | 2020 |
N-heterocyclic carbenes (NHC) with 1,2,4-oxadiazole-substituents related to natural products: synthesis, structure and potential antitumor activity of some corresponding gold(I) and silver(I) complexes.
Topics: Animals; Antineoplastic Agents; Biological Products; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gold; Heterocyclic Compounds; Humans; Methane; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Organometallic Compounds; Oxadiazoles; Silver; Structure-Activity Relationship | 2015 |
Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Heterocyclic Compounds; Humans; Ligands; Methane; Mice; Molecular Structure; Neoplasms, Experimental; Organogold Compounds; Structure-Activity Relationship | 2017 |